- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.32 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-BMA-FUC.4: 6 residues within 4Å:- Chain A: L.233, D.234, Y.245, C.253, N.255
- Ligands: SO4.19
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:Y.245
- Hydrogen bonds: A:D.234
- Water bridges: A:D.234
NAG-NAG-BMA-FUC.9: 4 residues within 4Å:- Chain B: R.252, V.254, N.255, F.258
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:V.254, B:F.258
- Water bridges: B:D.234, B:R.252
- 4 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG-FUC.5: 5 residues within 4Å:- Chain A: H.313, N.337, S.365, E.391
- Chain B: Q.177
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Q.177
NAG-NAG-FUC.6: 3 residues within 4Å:- Chain A: R.386, N.418, T.420
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:R.386
NAG-NAG-FUC.10: 6 residues within 4Å:- Chain B: H.313, N.337, E.363, S.365, R.389, E.391
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.11: 3 residues within 4Å:- Chain B: R.386, N.418, T.420
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.12: 3 residues within 4Å:- Chain A: N.15, N.16, T.18
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.15
NAG.13: 1 residues within 4Å:- Chain A: N.397
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.397
NAG.34: 3 residues within 4Å:- Chain B: H.21, E.24, N.25
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:E.24, B:E.24, B:N.25
- Water bridges: B:N.25
NAG.35: 1 residues within 4Å:- Chain B: N.397
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.397
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.14: 4 residues within 4Å:- Chain A: S.85, R.86, L.87, R.114
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.87
- Salt bridges: A:R.86, A:R.114
SO4.15: 4 residues within 4Å:- Chain A: N.343, R.345, R.371, R.372
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.343
- Water bridges: A:R.345
- Salt bridges: A:R.345, A:R.371, A:R.372
SO4.16: 3 residues within 4Å:- Chain A: I.341, K.369, R.371
5 PLIP interactions:5 interactions with chain A- Water bridges: A:R.371, A:E.394, A:E.394
- Salt bridges: A:K.369, A:R.371
SO4.17: 5 residues within 4Å:- Chain A: P.160, G.161, T.162, A.163, K.164
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.161, A:T.162, A:A.163, A:K.164
- Salt bridges: A:K.164
SO4.18: 3 residues within 4Å:- Chain A: E.318, K.319, T.320
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:T.320, A:T.320
- Water bridges: A:E.318, A:T.320
- Salt bridges: A:K.319
SO4.19: 3 residues within 4Å:- Chain A: S.257
- Ligands: NAG-NAG-BMA-FUC.4, NAG-NAG-BMA-FUC.4
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:S.257, A:S.257
SO4.36: 4 residues within 4Å:- Chain B: S.85, R.86, L.87, R.114
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Water bridges: A:R.118, A:E.120
- Hydrogen bonds: B:S.85, B:L.87
- Salt bridges: B:R.114
SO4.37: 3 residues within 4Å:- Chain B: D.221, T.223, R.236
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:R.236
- 1 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)
- 19 x GOL: GLYCEROL(Non-functional Binders)
GOL.21: 8 residues within 4Å:- Chain A: P.43, F.46, R.47, G.68, L.69, E.70, S.71, D.74
Ligand excluded by PLIPGOL.22: 4 residues within 4Å:- Chain A: L.206, C.207, P.219, D.220
Ligand excluded by PLIPGOL.23: 4 residues within 4Å:- Chain A: E.211, V.238, E.239, T.240
Ligand excluded by PLIPGOL.24: 2 residues within 4Å:- Chain A: R.114
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.2
Ligand excluded by PLIPGOL.25: 2 residues within 4Å:- Chain A: E.70, K.73
Ligand excluded by PLIPGOL.26: 5 residues within 4Å:- Chain A: S.134, R.135, K.197, S.198
- Ligands: NAG-NAG-BMA-MAN-MAN-MAN.2
Ligand excluded by PLIPGOL.27: 6 residues within 4Å:- Chain A: R.65, E.97, V.99, K.121, N.123
- Ligands: GOL.31
Ligand excluded by PLIPGOL.28: 6 residues within 4Å:- Chain A: N.123, L.147, N.148, K.149, D.151, N.152
Ligand excluded by PLIPGOL.29: 8 residues within 4Å:- Chain A: P.222, T.223, K.224, C.225, V.226, Y.232, G.235, C.237
Ligand excluded by PLIPGOL.30: 3 residues within 4Å:- Chain A: R.135, T.172, R.181
Ligand excluded by PLIPGOL.31: 4 residues within 4Å:- Chain A: R.65
- Chain B: R.14
- Ligands: P33.20, GOL.27
Ligand excluded by PLIPGOL.32: 4 residues within 4Å:- Chain A: H.429, Y.430, A.458, T.461
Ligand excluded by PLIPGOL.33: 3 residues within 4Å:- Chain A: S.217
- Ligands: NAG-NAG-BMA.3, NAG-NAG-BMA.3
Ligand excluded by PLIPGOL.38: 10 residues within 4Å:- Chain B: P.222, T.223, K.224, C.225, V.226, C.228, Y.232, G.235, R.236, C.237
Ligand excluded by PLIPGOL.39: 5 residues within 4Å:- Chain A: F.89
- Chain B: N.90, R.114, G.115, S.116
Ligand excluded by PLIPGOL.40: 3 residues within 4Å:- Chain B: T.320, K.369, R.371
Ligand excluded by PLIPGOL.41: 3 residues within 4Å:- Chain B: S.290, G.291, C.308
Ligand excluded by PLIPGOL.42: 6 residues within 4Å:- Chain A: L.87, F.88, F.89
- Chain B: Y.91, D.142, H.144
Ligand excluded by PLIPGOL.43: 2 residues within 4Å:- Chain B: D.404, Y.430
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lou, M. et al., The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc.Natl.Acad.Sci.Usa (2006)
- Release Date
- 2006-08-15
- Peptides
- Insulin receptor: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.32 Å
- Oligo State
- homo-dimer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 1 x P33: 3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL(Non-covalent)
- 19 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lou, M. et al., The first three domains of the insulin receptor differ structurally from the insulin-like growth factor 1 receptor in the regions governing ligand specificity. Proc.Natl.Acad.Sci.Usa (2006)
- Release Date
- 2006-08-15
- Peptides
- Insulin receptor: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B